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a b s t r a c t
FOG-2 is a multi-zinc ﬁnger protein that binds the transcriptional activator GATA4 and modulates
GATA4-mediated regulation of target genes during heart development. Our previous work has
demonstrated that the Nucleosome Remodeling and Deacetylase (NuRD) complex physically interacts
with FOG-2 and is necessary for FOG-2 mediated repression of GATA4 activity in vitro. However, the
relevance of this interaction for FOG-2 function in vivo has remained unclear. In this report, we
demonstrate the importance of FOG-2/NuRD interaction through the generation and characterization of
mice homozygous for a mutation in FOG-2 that disrupts NuRD binding (FOG-2R3K5A). These mice exhibit
a perinatal lethality and have multiple cardiac malformations, including ventricular and atrial septal
defects and a thin ventricular myocardium. To investigate the etiology of the thin myocardium, we
measured the rate of cardiomyocyte proliferation in wild-type and FOG-2R3K5A developing hearts. We
found cardiomyocyte proliferation was reduced by 3178% in FOG-2R3K5A mice. Gene expression analysis
indicated that the cell cycle inhibitor Cdkn1a (p21cip1) is up-regulated 2.070.2-fold in FOG-2R3K5A
hearts. In addition, we demonstrate that FOG-2 can directly repress the activity of the Cdkn1a gene
promoter, suggesting a model by which FOG-2/NuRD promotes ventricular wall thickening by repression
of this cell cycle inhibitor. Consistent with this notion, the genetic ablation of Cdkn1a in FOG-2R3K5A mice
leads to an improvement in left ventricular function and a partial rescue of left ventricular wall
thickness. Taken together, our results deﬁne a novel mechanism in which FOG-2/NuRD interaction is
required for cardiomyocyte proliferation by directly down-regulating the cell cycle inhibitor Cdkn1a
during heart development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
FOG-2 is a transcriptional co-factor that is known to play
important roles in cardiac, gonadal, and pulmonary development.
It is expressed in the heart during mid and late gestation, and then
continues to be expressed at a low level in the adult heart (Lu et al.,
1999; Svensson et al., 2000a, 1999; Tevosian et al., 1999). Most of its
functions in heart development are mediated through interaction
with the transcriptional activator GATA4 (Crispino et al., 2001).
FOG-2 deﬁcient mice die between embryonic day (E) 13.5 and 14.5
from heart failure due to cardiac malformations. These cardiac
structural abnormalities include a large common AV valve, atrial
and ventricular septal defects, hyperplastic endocardial cushions, an
overriding aorta, and a thin compact zone of the ventricular
myocardium (Svensson et al., 2000b; Tevosian et al., 2000).
In addition, mice deﬁcient in FOG-2 fail to form a subepicaridal
capillary plexus, the precursor to the mature coronary vasculature
(Tevosian et al., 2000).
In most cell and promoter contexts, the interaction of FOG-2
with GATA4 results in the transcriptional repression of target
genes. This occurs in part through the FOG-2 mediated recruit-
ment of other transcriptional repressive complexes and factors to
target promoters. One such transcriptional repressor is C-terminal
binding protein (CtBP), which physically interacts with FOG-2 via a
motif in the C-terminal half of the FOG-2 protein. However, this
interaction does not seem to be required for repression of target
genes in vitro, and it is unclear what role this interaction may play
in vivo (Holmes et al., 1999; Katz et al., 2002; Svensson et al.,
2000a). FOG-2 has also been shown to interact with COUP-TFII
in vitro, though the signiﬁcance of this interaction in vivo is also
unknown (Huggins et al., 2001).
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We have previously shown that the N-terminus of FOG-2 is
required for repression of FOG-2 targets in vitro, and that the 12 N-
terminal amino acids of FOG-2 are sufﬁcient to mediate repression
of a promoter when fused to a DNA binding domain (Lin et al., 2004;
Svensson et al., 2000a). This 12 amino acid motif is not required for
FOG-2's interaction with GATA4 or CtBP, and instead has been
shown to interact with components of the Nucleosome Remodeling
and Deacetylase (NuRD) complex. This motif is found not only in
both FOG-1 and FOG-2, but also at the N-termini of other transcrip-
tional modulators, some of which have roles in the regulation of
heart development, such as SALL1 and SALL4 (Bruneau, 2008; Gao et
al., 2010a; Hong et al., 2005; Kiefer et al., 2008; Lin et al., 2004;
Roche et al., 2008; Sakaki-Yumoto et al., 2006).
The NuRD complex has eight subunits: Mi2ß, RbAp46, RbAp48,
p66, MTA1, 2, or 3, and MBD3 (Wade et al., 1998; Xue et al., 1998;
Zhang et al., 1998). The N-terminus of both FOG-1 and FOG-2 has
been shown to physically interact with the MTA and RbAp subunits
of the NuRD complex both in vitro and in vivo. Mutation of critical
residues within this motif abolished binding to NuRD subunits, and
knock-down of MTA subunits in vitro abolished FOG-2-mediated
repression (Hong et al., 2005; Roche et al., 2008). The structure of
the interaction between the FOG repression motif of FOG-1 and
RbAp48 has been recently determined using x-ray crystallography,
conﬁrming the key amino acids in FOG proteins required for FOG-
NuRD interaction (Lejon et al., 2011). Previously, we have described
the generation and characterization of a mouse engineered to carry
speciﬁc mutations in the gene encoding FOG-1 (FOG-1R3K5A) that
disrupts the ability of FOG-1 to interact with the NuRD complex.
Mice homozygous for these mutations developed defects in hema-
topoetic development, demonstrating the importance of FOG-1/
NuRD interactions for the maturation of megakaryocytes and
erythrocytes in vivo (Gao et al., 2010a; Miccio et al., 2010).
To explore the importance of FOG-2/NuRD interactions for the
regulation of cardiac development, we set out to generate mice
with a targeted mutation in the gene encoding FOG-2 (Zfpm2,
hereafter referred to as FOG-2) that would disrupt the FOG-2/
NuRD interaction in vivo. In this report, we demonstrate that mice
homozygous for such a mutation (FOG-2R3K5A) have a near
complete perinatal lethality. The hearts of these mice have a
membraneous ventricular septal defect and left ventricular dys-
function due to a hypoplastic ventricular myocardium. Further, we
demonstrate upregulation of the cell-cycle inhibitor Cdkn1a
(p21cip1) in FOG-2R3K5A hearts due to a failure of mutant FOG-2
to repress the Cdkn1a promoter resulting from loss of FOG-2/NuRD
interaction. Genetically ablating Cdkn1a is able to partially rescue
the FOG-2R3K5A phenotype, demonstrating that FOG-2 modulation
of Cdkn1a expression is critical for the regulation of cardiomyocyte
proliferation during cardiac development.
Materials and methods
Generation of FOG-2R3K5A/R3K5A mice
Recombineering techniques were used to create a vector
harboring the R3K5A mutation in the ﬁrst exon of the gene
encoding FOG-2 while also adding a novel SacI restriction site
(Liu et al., 2003). The vector was linearized and electroporated into
129 S6/SvEv ES cells, clones of which were then screened using
Southern analysis for homologous recombination at the Zfpm2
locus using genomic probes outside the targeting vector from both
the 50 and 30 ends of the allele. ES cells that were correctly targeted
were then injected into C57BL/6 blastocysts to generate chimeric
mice. These mice were then bred further to obtain germline
transmission of the targeted allele. Heterozygotes were then bred
with Prm-cre transgenic mice from the Jackson laboratory (129S/
Sv-Tg(Prm-cre)580 g/J) to excise the neomycin cassette from the
allele, generating the FOG-2R3K5A allele (see Fig. 1). For rescue
experiments, FOG-2R3K5A/þ heterozygotes were crossed to
Cdkn1a / mice (line B6;129S2-Cdkn1atn1Tyj/J:JAX) obtained
from the Jackson Laboratory, after which double heterozygotes
were interbred. All mouse work was performed at the University
of Chicago according to the animal care and use guidelines.
Western analysis
Twenty-ﬁve micrograms of whole heart lysate from E13.5
mouse embryos from either wild-type, mutant, or heterozygote
siblings was resolved on a 7% SDS-PAGE gel and transferred to a
nitrocellulose membrane (Whatman, Piscataway NJ). The mem-
brane was then blocked as previously described (Gao et al., 2010b)
and incubated with 1:1000 dilution of rabbit anti-FOG-2 antibody
(M247, Santa Cruz Biotechnology) rocking overnight at 4 1C, then
washed and incubated with HRP-coupled goat anti-rabbit IgG
diluted 1:5000 (Jackson ImmnoResearch) for 3 h at room tem-
perature. The membrane was developed using the ECL-plus kit
(Amersham) and exposed to ﬁlm. To assure equal protein loading
between lanes, the membrane was then stripped and re-probed
for HSP90 using a 1:5000 dilution of a rabbit anti-HSP90 antibody
(H-114, Santa Cruz Biotechnology).
Transient transfection and promoter analysis
p638ANF-Luc, pcDNA-FOG-2, pcDNA-GATA4, pVR-beta-galacto-
sidase have been described previously (Knowlton et al., 1991;
Svensson et al., 1999), pcDNA-FOG-2R3K5A was created by making
a targeted mutation in pcDNA-FOG-2 using PCR with primers (50-
GAAATGTCCGCGCGAGCTCAGAGTAAACCCCGGCAGATCAAACG and 50-
TACTCTGAGCTCGCGCGGACATTTCGGCCGCGGCCGCTGCCGCTG), result-
ing in a mutant version of FOG-2 that encodes alanine at amino acid
position 3 and 5 instead of arginine and lysine, respectively. After
construction, the vector was sequenced to conﬁrm creation of pcDNA-
FOG2R3K5A. The construct p21-Luc was generated by tailed PCR of 2 kb
of the Cdkn1a promoter region using the following tailed primers:
50-CGGCTCGAGTGTCTAGGTCAGCTAAATCCGAGG and 50-CGCAAGCT-
TAAGCTCTCACCTCTGAATGTCTGG. The resultant PCR product was then
digested with XhoI and HindII, ligated into pGL2basic vector, and
conﬁrmed by sequencing to create p21-Luc reporter plasmid. Transient
transfection into NIH 3T3 ﬁbroblasts was performed as previously
described (Kim et al., 2009). Cells were harvested and lysed with
100 uL/well of Reporter Lysis Buffer (Promega). Cell lysates were then
frozen at 20 1C and thawed before assay in the Glomax 20/20
Luminometer (Promega) using 20 uL of cell lysate and 100 uL Lucifer-
ase Assay Substrate (Promega). Beta-galactosidase activity assays were
performed as described previously (Kim et al., 2009; Lin et al., 2004).
Luciferase activity was normalized to β-galactosidease activity to
control for transfection efﬁciency. Each experiment was performed
in triplicate in three independent experiments and results presented
as the mean7S.E.M. A Student's t-test was performed between each
set of experimental conditions to determine statistical signiﬁcance.
Echocardiography
Newborn FOG-2R3K5A pups were subject to echocardiography using
a VisualSonics Vevo 770 machine with a 30MHz transducer. Mice
were placed on a 37 1C warming pad and lightly sedated with 1%
isoﬂurane. Conscious imaging was performed to acquire two-
dimensional parasternal short axis M-mode images. Percent left
ventricular fractional shortening was calculated as [(diastolic left
ventricular internal diameter - systolic left ventricular internal dia-
meter)/diastolic left ventricular internal diameter]100. A Student's
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t-test was performed between each set of experimental conditions to
determine statistical signiﬁcance.
Microarray data and analysis
Affymetrix GeneChip Mouse Genome 430 2.0 microarrays were
used for analysis of expression of RNA isolated from E16.5 wild-type
and FOG-2R3K5A whole hearts. This microarray data is available under
accession GSE50426 in the GEO database. Analysis of results was
performed using dChip (Li and Wong, 2001) and Ingenuity Pathway
Analysis (IPA) software (Ingenuity Systems). dChip identiﬁed 670
probe sets that were misregulated by at least 1.3-fold in the FOG-
2R3K5A hearts. Using these probe sets, IPA identiﬁed 41 networks
consisting of 332 misregulated focus molecules. Three hundred ten of
the original 332 focus molecules fell into 19 networks containing more
than one focus molecule. We grouped the networks with multiple
focus molecules into 7 super-networks based on the descriptions of
network function provided by IPA (Supplementary Table 2).
In order to generate a heat map of mis-regulated cell cycle
genes, we generated a list of genes on the microarray chip
associated with the following gene ontology terms: regulation of
cell cycle, positive regulation of cell cycle, negative regulation of
cell cycle, mitosis, cell proliferation, cell division, and cell cycle. We
then used dChip to identify the genes on this list that were
misregulated at least 1.3-fold. Hierarchical clustering by dChip
was used to generate a heatmap of these genes to visualize the
trends in their misregulation.
Proliferation assays
To measure the rate of cardiomyocyte proliferation in the hearts
of developing embryos, we developed an immunoﬂuorescence
approach to co-stain histologic sections from E16.5 mouse embryos
with antibodies to phosphohistone-H3 (PH3, Cell Signaling) to mark
proliferating cells, and to myosin heavy chain (MF20, Developmental
Studies Hybridoma Bank, University of Iowa) to mark cardiomyo-
cytes. Brieﬂy, sections were prepared, processed, and incubated with
an anti-phosphohistone H3 antibody as described previously (Flagg
et al., 2007). Following this incubation, sections were washed and
incubated overnight at 4 1C with the MF20 antibody diluted 1:100 in
a blocking solution of 1% BSA and 5% normal goat serum in PBS. The
sections were then washed 3 times for 15 min in PBS, and a Donkey
anti-Mouse antibody conjugated to Cy3 (715-165-150, Jackson
ImmunoResearch) was added to the slides at a 1:200 dilution
concurrently with the secondary antibody for PH3 (Flagg et al.,
2007). Following this incubation, sections were washed with PBS,
co-stained with DAPI, and then immunoﬂuorescence was visualized
using a Zeiss Axiphot ﬂuorescence microscope. Digital images were
captured and cell counting of DAPI-stained cell nuclei was per-
formed in Image J. Phosphohistone-H3 positive cells that were also
MF-20 positive were counted manually. The proliferation index was
calculated by dividing the number of mitotic cardiomyocytes (cells
stained by both MF20 and PH3) by the total number of DAPI-positive
cells in the ventricular myocardium of each section. At least
7 sections from each heart were analyzed from each of 3 wild type
and 3 mutant embryos. A Student's t-test was performed between
each set of experimental conditions to determine statistical
signiﬁcance.
Quantitative RT-PCR
Hearts from E16.5 embryos were harvested in RNAse-free
conditions and frozen in liquid nitrogen, then divided into three
biological replicates of each genotype, containing at least two
hearts in each replicate. Total RNA was then extracted with Trizol
(Invitrogen) and cDNA was prepared with qScript cDNA SuperMix
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Fig. 1. Generation of FOG-2R3K5A mice. In (A), a schematic of the targeting strategy for generation of FOG-2R3K5A animals centered on the ﬁrst exon of the Zfpm2 gene,
represented by a black box. E¼EcoRI restriction site, S¼SacI restriction site, black triangles¼position of LoxP sites, neo¼neomycin resistance cassette. In (B), Southern
analysis of tail DNA from offspring of chimeric mice, using the indicated probe and EcoRI restriction digestion, demonstrating germline transmission of the targeted locus. In
(C), PCR assay from mouse genomic DNA using primers P1 and P2 showing expected size bands for wild-type (WT) and R3K5A allele. (D) Western blot of embryonic day 13.5
heart lysate using an antibody against FOG-2 (top panel) or heat shock protein 90 as a loading control (HSP90, bottom panel), demonstrating no qualitative change in the
levels of FOG-2 in wild-type, heterozygous, or R3K5A homozygous mutant hearts.
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(Quanta Biosciences, Gaithersburg MD). Quantitative PCR was then
performed using DyNAmo HS SYBR Green qPCR kit (Thermo Fisher
Scientiﬁc, Waltham MA), with primers as listed in Supplementary
Table 1 for at least three independent experiments on each
biological replicate. Results were analyzed using the previously
described methods (Gao et al., 2010b; Tichopad et al., 2003) and
were normalized to levels of Gapdh to control for variation in
cDNA quantity. A Student's t-test was performed between each set
of experimental conditions to determine statistical signiﬁcance.
Quantitation of ventricular wall thickness
Wild-type, FOG-2R3K5A, and FOG-2R3K5A;Cdkn1a / double
mutant newborn mice were harvested, ﬁxed in 10% formalin,
and embedded in parafﬁn. Transverse sections through the hearts
were then prepared and stained with hemotoxylin and eosin.
Photographs of comparable sections were obtained using a Zeiss
Axiophot microscope. Left ventricular wall thickness was mea-
sured from the base of the trabecular zone to the epicardium from
8 sections each from 3 hearts of each genotype at the thinnest
point of the apical-lateral wall of the left ventricle. Results are
reported as the mean7S.E.M. for each genotype. A Student's t-test
was used to determine statistical signiﬁcance.
Results
A mutation in the N-terminal motif of FOG-2 abrogates FOG-2
mediated repression of GATA-4 induced transcriptional activity
As we and others have previously shown, the ﬁrst 12 N-
terminal amino acids of FOG-1 and FOG-2 are highly conserved
and are required for full repressive activity of both FOG-1 and
FOG-2 (Hong et al., 2005; Lin et al., 2004; Roche et al., 2008;
Svensson et al., 2000a). These amino acids, termed the FOG
repression motif, physically interact with the MTA and RbAp
components of the NuRD complex, resulting in the recruitment
of the NuRD complex to target promoters (Gao et al., 2010a; Roche
et al., 2008). Mutation of amino acids within this motif results in a
loss of binding to MTA and RbAp proteins and a loss of repressive
activity in vitro (Gao et al., 2010a; Hong et al., 2005; Roche et al.,
2008). Further, generation of mice with substitution of the 3rd and
5th amino acids for alanine (R3K5A) in FOG-1 results in the failure
to recruit the NuRD complex to target promoters and the attenua-
tion of FOG-1 target gene repression in vivo (Gao et al., 2010a;
Miccio et al., 2010).
To conﬁrm that a similar mutation in the gene encoding FOG-2
also blocks FOG-2-mediated transcriptional repression, we gener-
ated a mammalian expression vector that encodes FOG-2 with the
R3K5A mutation (pcDNA-FOG-2R3K5A). We then transiently trans-
fected NIH3T3 cells, which endogenously express the components
of the NuRD complex, with a vector containing the atrial naturetic
factor (ANF) promoter driving expression of the reporter gene
luciferase. In addition, we also included expression vectors for the
transcriptional activator GATA4 as well as FOG-2 (Supplemental
Fig. 1). In the presence of GATA4, the ANF promoter was activated
139736 fold. Further, the addition of wild-type FOG-2 resulted in
an almost complete repression of GATA4-mediated transactivation
of the ANF promoter. In contrast, expression of the FOG-2R3K5A
protein was unable to signiﬁcantly repress GATA-4 activated
transcription of the ANF promoter in NIH3T3 cells in this transient
transfection assay. These results are consistent with our previous
results and show the importance of these residues for FOG-2
mediated repression by the NuRD complex (Gao et al., 2010a; Lin
et al., 2004; Roche et al., 2008; Svensson et al., 2000a).
Creating a mouse harboring the FOG-2R3K5A mutation
In order to determine the importance of FOG-2/NuRD interac-
tions in heart development, we created a mouse harboring the
R3K5A mutation in the endogenous Zfpm2 locus that would
produce a mutant version of FOG-2 unable to interact with the
NuRD complex in vivo (Fig. 1A). Exon 1 of the Zfpm2 gene encodes
the translational start site and the ﬁrst 13 amino acids of FOG-2.
Using site directed mutagenesis on a plasmid containing this
region of the FOG-2 gene, mutations in 5 base pairs were
introduced resulting in the generation of a novel SacI site in Exon
1. This also resulted in a change in the codons corresponding to
amino acids 3 and 5 of FOG-2, changing them from arginine and
lysine to alanine. This plasmid was then used to generate an ES cell
targeting vector which was transfected into murine ES cells.
Neomycin-resistant ES cell clones were screened using Southern
analysis for ES cells that had undergone homologous recombina-
tion at the Zfpm2 locus (data not shown). Correctly targeted ES
cells were microinjected into blastocysts to generate chimeric
mice. These chimeras were then bred to achieve germline trans-
mission of the target locus as demonstrated by Southern analysis
(Fig. 1B). The neomycin resistance cassette was removed from the
altered Zfpm2 locus by crossing mice carrying this allele to mice
that express Cre in cells of their germline (Prm-cre transgenic
mice). Cre-mediated excision of the targeted locus resulted in the
removal of the neomycin cassette in the germline of the progeny
from this cross, leaving behind the targeted mutations in exon
1 and just one loxP site in the ﬁrst intron of the gene (Fig. 1A
and C).
FOG-2R3K5A mice die perinatally
Mice heterozygous for the targeted allele lacking the neomycin
cassette (FOG-2R3K5A/þ) are viable and fertile, exhibit no grossly
apparent malformations, and have a normal lifespan. As a ﬁrst step
in our analysis of homozygous FOG-2R3K5A/R3K5A mice, we crossed
male and female FOG-2R3K5A/þ mice to generate FOG-2R3K5A/R3K5A
mice (hereafter referred to as FOG-2R3K5A mice) and analyzed the
genotypes of the progeny from this cross at different times in
development (Table 1). Our results demonstrate that FOG-2R3K5A
mice die shortly after they are born. In utero, the genotypes of
embryos from crosses between heterozygotes conformed to a
1:2:1 Mendelian ratio. However, after birth, FOG-2R3K5A mice were
under-represented, and by weaning nearly all mutants were dead
(Table 1). Those few FOG-2R3K5A mice that survived to weaning
died shortly thereafter, demonstrating a fully penetrant lethality of
the FOG-2R3K5A allele. Western analysis of E13.5 hearts demon-
strated that the overall level of FOG-2 produced in wild-type
hearts compared to FOG-2R3K5A hearts is comparable (Fig. 1D),
suggesting that the critical regulatory elements controlling expres-
sion of FOG-2 were not perturbed by introduction of the targeted
mutations.
Table 1
Genotype analysis of progeny from FOG-2R3K5A/þ heterozygous crosses. FOG-2R3K5A
mice were crossed and resultant mice harvested as embryos (E13.5-E18.5), as
newborns (P0-P3), or at weaning (P14-P21) and genotyped using a PCR-
based assay.
Genotype þ /þ R3K5A/þ R3K5A/R3K5A
Embryonic 35 (29%) 54 (45%) 30 (25%)
Newborn 25 (33%) 39 (51%) 12 (16%)
Weaning 42 (33%) 82 (65%) 2 (2%)
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Dilated cardiomyopathy and septal defects in FOG2R3K5A hearts
To determine the cause of the perinatal lethality in the FOG-2R3K5A
mice, we performed echocardiography on newborn pups (Fig. 2).
In mutant mice, we observed a trend toward an increase in left
ventricular end-diastolic dimension (1.3870.06 mm vs. 1.627
0.09 mm), a signiﬁcant increase in left ventricular end-systolic dimen-
sion (0.7370.03 mm vs. 1.1070.06 mm, po0.001), and a signiﬁcant
reduction in the fractional shortening (47.371.5% vs. 31.471.6%,
po0.0001). Taken together, these results suggest that the FOG-
2R3K5A mice die of systolic heart failure. To look more closely at the
hearts of FOG-2R3K5A mice, we performed a histologic analysis (Fig. 3).
FOG-2R3K5A hearts showed several morphogenic abnormalities. First,
all FOG-2R3K5A hearts had an ostium secundum atrial septal defect
(ASD) (Fig. 3A and B) and a membranous ventricular septal defect
(VSD) (Fig. 3C and D). Additionally, FOG-2R3K5A hearts had a very thin,
dilated left ventricular wall. Interestingly, the valves of FOG-2R3K5A
hearts appear to be grossly normal, unlike FOG-2 deﬁcient mice,
which have hyperplastic endocardial cushions by E12.5 (Flagg et al.,
2007; Svensson et al., 2000b). Further, formation of coronary vascular
plexus, which fails to develop in FOG-2 deﬁcient mice (Tevosian et al.,
2000), forms with only a slight delay in FOG-2R3K5A hearts; at E13.5
the vessels are clearly not branching completely over the dorsal
surface of the ventricles, but by E14.5 they appear normal
(Supplemental Fig. 2). This supports the notion that the R3K5A
mutation only abrogates a subset of the functions performed by
FOG-2 in development of the heart. Speciﬁcally, the N-terminal
repression motif in FOG-2 is required to direct proper development
of the ventricular and atrial septa and of the ventricular wall, but not
of the coronary vasculature or the cardiac valves.
FOG-2R3K5A mice have a cardiomyocyte proliferation defect during
embryogenesis
In order to determine genes misregulated in FOG-2R3K5A hearts
that would explain the thin ventricular wall phenotype, we
performed microarray analysis on wild-type and FOG-2R3K5A
hearts at E16.5, as this is developmental timepoint at which the
FOG-2R3K5A thin wall phenotype is ﬁrst apparent on histological
analysis (data not shown). This microarray data is available under
accession GSE50426 in the GEO database. Analysis of the resultant
data using dChip and Ingenuity Pathway Analysis software identi-
ﬁed 19 gene networks containing more than one focus molecule
misregulated by greater than 1.3-fold in the hearts of FOG-2R3K5A
mice. We then further grouped these 19 networks into 7 super-
networks based on their functional description (Fig. 4A,
Supplemental Table 2). The super-networks with the most focus
molecules have functions in cell proliferation and cell death, while
the super-network with the third most focus molecules is asso-
ciated with other general developmental processes (Fig. 4A). Given
these results and previous observations demonstrating the impor-
tance of cardiomyocyte proliferation during this time point in
development (Ahuja et al., 2007), we hypothesized that the thin
walled phenotype in the FOG-2R3K5A mice was due to either a
failure of cardiomyocyte proliferation or an abnormal increase in
cardiomyocyte apoptosis.
In order to differentiate between these possibilities, we mea-
sured the rate of apoptosis and the rate of proliferation of
cardiomyocytes in wild-type and FOG-2R3K5A hearts at E16.5, the
developmental timepoint when the walls ﬁrst appear thinner by
histology (data not shown). To measure apoptosis, we used an
immunoﬂuorescence-based assay to detect TUNEL positive cells
that also expressed myosin heavy chain on sections of E16.5 hearts
from wild-type and FOG-2R3K5A embryos (Supplemental Fig. 3).
Cardiomyocyte apoptosis was extremely rare in the developing
heart and was not signiﬁcantly altered in FOG-2R3K5A hearts,
demonstrating that an increase in apoptosis is not the cause of
the thin ventricular compact zone. To examine cardiomyocyte
proliferation in these mice, a similar approach was taken using an
antibody against phosphohistone H3, a marker of proliferating
cells (Fig. 5). In wild-type embryos, cardiomyoctye proliferation
was readily apparent, with an overall cardiomyocyte proliferation
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Fig. 2. FOG-2R3K5A mice have Left Ventricular Dysfunction at Birth. Echocardiographic M-mode tracings of (A) wild-type and (B) FOG-2R3K5A newborn mice. Arrows indicate
left ventricular end diastolic dimension (LVEDD) and left ventricular end systolic dimension (LVESD). In (C–E), quantiﬁcation of LVEDD, LVESD, and fractional shortening of
wild-type and FOG-2R3K5A mice expressed as the mean7S.E.M. (n¼6), demonstrating a signiﬁcant increase in LVESD and a signiﬁcant reduction in fractional shortening of
FOG-2R3K5A mice.
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Fig. 3. FOG-2R3K5A mice have Atrial and Ventricular Septal Defects and a Dilated Cardiomyopathy at Birth. Wild-type (A, C, E) and FOG-2R3K5A (B, D, F) mice were harvested at
postnatal day 3 and transverse sections through the heart prepared and stained with hematoxylin and eosin. Note the atrial septal defect (B, arrow) and ventricular septal
defect (D, arrow) in the FOG-2R3K5A mice, and the thin LV myocardial wall (indicated by arrows in panels E and F). LV¼Left Ventricle, RV¼Right Ventricle.
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Fig. 4. Microarray Analysis of FOG-2R3K5A Hearts demonstrates Misregulation of Cell Cycle Related Genes. In (A), percentage of genes in the indicated super-networks as
determined by Ingenuity Pathway Analysis. In (B), a heatmap for cell cycle and proliferation related genes that are misregulated more than 1.3-fold in hearts of FOG-2R3K5A
mice. Expression levels for each gene are standardized to a mean of 0 and standard deviation of 1; pure red represents a standardized expression level of 3 or more, and pure
blue represents -3 or lower.
A.S. Garnatz et al. / Developmental Biology 395 (2014) 50–61 55
index of 0.66370.049 proliferating cells per 100. In contrast, the
number of proliferating cardiomyocytes in FOG-2R3K5A embryos
was only 0.46070.024 cells per 100, a 31% decrease in FOG-2R3K5A
ventricles as compared to their wild-type littermates (Fig. 5). This
result strongly suggests that the thin ventricular wall seen in FOG-
2R3K5A hearts is due to a cardiomyocyte proliferation defect.
The cell-cycle inhibitor p21cip1 is signiﬁcantly upregulated in mutant
hearts and is a target of FOG-2/NuRD-mediated repression
To begin to elucidate the FOG-2 dependent molecular pathway
that regulates cardiomyocyte proliferation, we re-examined our
microarray data for clues that would explain a lack of cardiomyo-
cyte proliferation. Using dChip and gene ontology analysis, we
generated a heatmap of misregulated cell cycle and proliferation
genes (Fig. 4B). Since the NuRD complex is known to promote a
closed chromatin state and repress gene expression, direct tran-
scriptional targets of FOG-2/NuRD should be overexpressed in
FOG-2R3K5A hearts. Notably, the cell cycle inhibitor p21cip1
(encoded by Cdkn1a), a cell cycle inhibitor that binds to G1 and
M CDK-cyclin complexes and inhibits their function to drive
forward the cell cycle (Ahuja et al., 2007), appeared to be over-
expressed in FOG-2R3K5A hearts, thus providing a potential gene
target for FOG-2/NuRD that might explain the proliferation defect
seen in FOG-2R3K5A cardiomyocytes. To conﬁrm these results, we
used quantitative RT-PCR to evaluate the expression of a panel of
cell-cycle genes in FOG-2R3K5A cardiomyocytes at E16.5 (Fig. 6A).
Consistent with our microarray results, we found that Cdkn1a is
transcriptionally up-regulated 2.0170.24-fold in FOG-2R3K5A
hearts, while the expression of other cell-cycle regulators were
unchanged, including other cell-cycle regulators suggested by our
microarray analysis (Mycn, Fgf9, and Fgfr2). The expression of
Cdkn1a is known to be up-regulated by the p53 tumor suppressor
gene (Trp53) in response to DNA damage, but Cdkn1a can also be
regulated independently and is induced without need for the
presence of p53 in other contexts, such as differentiation of
murine erythroleukemia cells (Macleod et al., 1995). Notably, in
FOG-2R3K5A hearts, Trp53 expression is unchanged (Fig. 6A), and
thus up-regulation of Cdkn1a in FOG-2R3K5A hearts is p53-
independent in this context.
The NuRD complex subunit MTA1 has been previously
described at the Cdkn1a promoter independent of p53 in DNA
damage response (Li et al., 2010), which supports the idea that
Cdkn1a could be a target of NuRD during heart development as
well. To determine if the Cdkn1a promoter may be a direct target
of FOG-2/NuRD, we ﬁrst analyzed the Cdkn1a promoter for
potential DNA binding sites for the FOG-2 interacting protein
GATA4. Analysis of the Cdkn1a promoter using the online software
algorithm Transcription Element Search System (TESS) (Schung
and Overton, 1998) revealed 28 putative GATA binding sites in a
2 kb fragment of the Cdkn1a promoter (data not shown). This
result suggested that Cdkn1a was a potential direct target of
GATA4 and thus may also be a target of FOG-2/NuRD in developing
cardiomyocytes.
To demonstrate a direct effect of FOG-2 on the Cdkn1a promo-
ter, we cloned the Cdkn1a promoter into the luciferase reporter
vector pGL2basic and performed in vitro transient transfection
assays in NIH3T3 mouse ﬁbroblasts. As shown in Fig. 6B, GATA4 is
able to directly activate this promoter, and FOG-2 effectively
represses GATA4-mediated transcriptional activation. FOG-2R3K5A,
however, fails to repress transcription from the Cdkn1a promoter,
showing that its recruitment of the NuRD complex (which is
expressed endogenously in these ﬁbroblasts) is important for
repression of the Cdkn1a promoter in this system (Fig. 6B). Taken
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Fig. 5. Proliferation in FOG-2R3K5A Ventricular Myocardium is Decreased. Representative sections of embryonic day 16.5 wild-type (A) and FOG-2R3K5A (B) hearts subject to
immunoﬂuorescence using an anti-phospho-histone H3 antibody to detect proliferating cells (green), and antibody to MF-20 to deﬁne myocytes (red), and counterstaining
with DAPI to detect nuclei (blue). Arrows indicate phospho-histone H3 positive cells. In (C), quantiﬁcation of the proportion of proliferating cardiomyocytes compared to the
total number of cells in the ventricular myocardium (proliferation index) expressed as the mean7S.E.M. At least seven depth-matched sections from three pairs of wild-type
and three FOG-2R3K5A hearts were analyzed.
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together, these results are consistent with a model in which the
lack of FOG-2-mediated recruitment of the NuRD complex at the
Cdkn1a promoter in FOG-2R3K5A cardiomyocytes leads to abnormal
activation of the Cdkn1a promoter, resulting in overexpression of
p21cip1 and the suppression of cardiomyocyte proliferation and a
thin myocardial wall phenotype.
Rescue of myocardial compact zone development and function in
FOG-2R3K5A mice with genetic removal of Cdkn1a
To provide further evidence for the importance of the repres-
sion of Cdkn1a during heart development, we sought to rescue the
FOG-2R3K5A phenotype by genetically ablating the expression of
p21cip1. Mice that are deﬁcient for Cdkn1a are viable and fertile,
although they are radiation-sensitive (Komarova et al., 2000). No
defects have been described in the developing myocardium of
Cdkn1a deﬁcient mice and histology of Cdkn1a deﬁcient hearts at
birth is indistinguishable from that of wild type siblings (compare
panels A and B in Fig. 7). Thus, loss of this cell cycle inhibitor alone
does not cause over-proliferation and thickening of the ventricular
wall. We next crossed FOG-2R3K5A mice to Cdkn1a null mice in
order to obtain FOG-2R3K5A; Cdkn1a / double mutant mice. As
we showed previously, FOG-2R3K5A hearts have a thin compact
zone (Fig. 7C), while FOG-2R3K5A; Cdkn1a/ double mutants have
a signiﬁcantly thicker myocardial compact zone at birth (compare
panels C and D in Fig. 7). However, wall thickness in the double
mutant mice is still not completely normal, with only a modest
26.873.2% rescue of wall thickness (po0.0001) when compared
to the left ventricular wall of wild-type mice (Fig. 7E).
To determine if this increase in wall thickness in the FOG-
2R3K5A; Cdkn1a / mice was functionally signiﬁcant, we examined
neonatal mice from double heterozygous crosses at P0 by echo-
cardiography (Fig. 8). As expected, wild-type and Cdkn1a/ left
ventricular function are not signiﬁcantly different as determined
by chamber dimensions or fractional shortening (Fig. 8). Consis-
tent with our results shown in Fig. 2, FOG-2R3K5A hearts have a
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Fig. 6. Cdkn1a is a Direct Target Gene of FOG-2/NuRD Chromatin Remodeling. In (A), total RNA was isolated from wild-type and FOG-2R3K5A E16.5 hearts and subject to
quantitative RT-PCR using primers speciﬁc for a panel of cell cycle genes. Results were normalized to expression of Gapdh and are expressed as the mean7S.E.M. of the ratio
of expression levels observed in FOG-2R3K5A vs. wild-type hearts. ‘**’ indicates statistical signiﬁcance (po0.01). In (B), NIH3T3 ﬁbroblasts were transiently transfected with a
reporter vector containing the Cdkn1a promoter driving expression of luciferase. In addition, expression vectors for GATA4, FOG-2, and FOG-2R3K5A were also included as
indicated. Forty-eight hours after transfection, cells were harvested and assayed for luciferase activity. Results were normalized for transfection efﬁciency, and reported as
the mean7S.E.M. (n¼12) relative to the activity of the Cdkn1a promoter alone.
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reduction in systolic function as determined by fractional short-
ening. However, in FOG-2R3K5A; Cdkn1a/ hearts, left ventricular
fractional shortening is preserved (Fig. 8G), demonstrating that the
increased wall thickness seen by histology in these mice does
improve left ventricular function. However, by postnatal day 14,
the survival of FOG-2R3K5A; Cdkn1a / is no better than that of
their FOG-2R3K5A siblings. This may be due to atrial and ventricular
septal defects that are still present in the FOG-2R3K5A; Cdkn1a /
mice (Supplemental Fig. 4). In addition, although fractional short-
ening is unchanged in the FOG-2R3K5A;Cdkn1a / mice, the left
ventricular end diastolic dimension is slightly increased when
compared to wild type mice (1.37 vs. 1.19 mm, p¼0.07, Fig. 8E),
suggesting that these hearts are beginning to dilate and fail. Taken
together, these results demonstrate that the ablation of Cdkn1a can
partially compensate for the loss of FOG-2-NuRD interaction
during cardiac development.
Discussion
Gene regulation by chromatin remodeling is increasingly being
appreciated to be important in the development of the mamma-
lian heart (Bruneau, 2010; Han et al., 2011). In this report, we
provide evidence to support the notion that the NuRD chromatin
remodeling complex is also important for heart development. Our
results demonstrate that when the NuRD complex is unable to
interact with FOG-2 (and is thus unable to be recruited to FOG-2
target gene promoters) mice develop cardiac defects, which
Fig. 7. Inactivation of Cdkn1a Partially Rescues Ventricular Wall Thickness in FOG2R3K5A Hearts. Mice deﬁcient for Cdkn1a were crossed to FOG-2R3K5A/þ mice to generate
compound mutants. Pups from these crosses were harvested at birth and H&E stained histologic sections through the heart were prepared. Representative sections from
wild-type, Cdkn1a/ , FOG-2R3K5A; Cdkn1aþ /þ , and FOG-2R3K5A; Cdkn1a  / mice are shown in panels (A–D), respectively. In each panel, the dashed line demarcates the
boundary between the myocardial compact zone and the trabecular zone. Arrows demonstrate the thickness of the compact zone. In panel (E), quantiﬁcation of left
ventricular wall thickness of wild-type, Cdkn1a/ , FOG-2R3K5A; Cdkn1aþ /þ , and FOG-2R3K5A; Cdkn1a/ hearts expressed as the mean7S.E.M. (n¼24). Eight sections from
3 hearts of each genotype were analyzed.
A.S. Garnatz et al. / Developmental Biology 395 (2014) 50–6158
include atrial and ventricular septal defects as well as a thin
ventricular myocardium. These defects result in left ventricular
dysfunction and lead to death shortly after birth. We demonstrate
that the thin myocardium is partially due to overexpression of the
cell cycle inhibitor p21cip1, and that the genetic ablation of Cdkn1a
partially rescues the wall thickness defect and improves left
ventricular function. We also show Cdkn1a is a target of FOG-2/
NuRD transcriptional repression in NIH3T3 ﬁbroblasts, thus deﬁn-
ing a chromatin remodeling dependent molecular pathway for the
regulation of cell cycle control during cardiac development.
The morphologic defects seen in the FOG-2R3K5A mice are only
a subset of those seen in mice with a complete disruption of the
gene encoding FOG-2. FOG-2 deﬁcient mice die between E13.5
and E14.5 with defects in cardiac development that include
Fig. 8. Inactivation of Cdkn1a Rescues Left Ventricular Function in FOG-2R3K5A hearts. Representative M-mode echocardiography tracings from wild-type, Cdkn1a/ , FOG-
2R3K5A; Cdkn1aþ /þ , and FOG-2R3K5A; Cdkn1a / mice at P0 are shown in panels (A–D), respectively. LVEDD (left ventricular end diastolic dimension) and LVESD (left
ventricular end systolic dimension) are indicated by arrows. In (E–G), quantitation of the LVEDD, LVESD, and fractional shortening in all four genotypes. Values are expressed
as expressed as the mean7S.E.M. Wild-type (n¼10), Cdkn1a/ (n¼7), FOG-2R3K5A; Cdkn1aþ /þ (n¼4), FOG-2R3K5A; Cdkn1a/ (n¼4).
A.S. Garnatz et al. / Developmental Biology 395 (2014) 50–61 59
hyperplastic endocardial cushions, an overriding aorta, a common
AV valve, atrial and ventricular septal defects, hypoplastic ventri-
cular walls, and a failure to form the coronary vascular plexus
(Svensson et al., 2000b; Tevosian et al., 2000). In the FOG-2R3K5A
mice, the endocardial cushions and atrioventricular valves appear
normal, suggesting that the role FOG-2 plays in development of
the heart valves may not be dependent on its interaction with the
NuRD complex. In addition, FOG-2/NuRD interactions also do not
appear to be necessary for the development of coronary vascular
plexus, as there is only a slight delay in their development in FOG-
2R3K5A mice (see Supplemental Fig. 2). NuRD independent func-
tions of FOG-2 may be partially explained by the ability of FOG-2
to interact with other repressive factors such as C-terminal
binding protein (CtBP) or COUP-TFII (Holmes et al., 1999;
Huggins et al., 2001; Svensson et al., 2000a), but it is unclear
what role these interactions may play during cardiac development.
The NuRD complex is likely to also play other roles in the
development of the heart other than those we have observed due to
disruption of its interaction with FOG-2. FOG-1 is also expressed in
the valves of the developing heart and its loss leads to cardiac
defects reminiscent of those seen in the endocardial cushions of
FOG-2 deﬁcient mice (Katz et al., 2003; Svensson et al., 2000b;
Tevosian et al., 2000). The co-expression of both FOG-1 and FOG-2
in the developing valves suggests that FOG-1 may also mediate
some NuRD-dependent function in this tissue, and that FOG-1/
NuRD may play redundant roles with FOG-2/NuRD. Redundancy of
FOG/NuRD function may also explain the lack of a phenotype in the
developing valves of FOG-2R3K5A mice. It is also likely that there are
FOG-independent functions of NuRD via NuRD's interaction with
other transcriptional regulators during heart development. The N-
terminal repression motif of FOG proteins that mediates interaction
with the NuRD complex is also found in several other transcrip-
tional repressors that are known to be involved in heart develop-
ment, notably SALL1 and SALL4, the causative genes of Okihiro
syndrome and Townes–Brokes, respectively (Kiefer et al., 2008; Lin
et al., 2004; Sakaki-Yumoto et al., 2006). It is possible that at least
part of the role of SALLs in heart development is also mediated by
its interaction with the NuRD complex.
The function of FOG-2/NuRD to repress Cdkn1a transcription in
the developing myocardium ﬁts into a broader picture describing
the regulation of the cardiomyocyte cell cycle during cardiac
development. It has previously been shown that GATA4 activates
expression of cell cycle proliferation genes, speciﬁcally Cdk4 and
Ccnd2 (Cyclin D2) in the developing heart (Rojas et al., 2008).
Previous work has also shown that GATA4 and GATA5 negatively
regulate Cdkn2c (p18), Cdkn1a (p21cip1), Cdkn1b (p27), and Cdkn1c
(p57) in cardiomyocytes, also leading to increased cell prolifera-
tion (Singh et al., 2010). Taken together, these results suggest
GATA4 is a critical regulator of cardiomyocyte proliferation. We
show that FOG-2/NuRD regulates the promoter of the cell cycle
inhibitor Cdkn1a in the developing heart to mediate its transcrip-
tional repression likely through FOG-2's interaction with GATA4.
Interestingly, we do not see changes in levels of other cell cycle
inhibitors in FOG-2R3K5A hearts, suggesting that other mechanisms
may be involved in the regulation of Cdkn2c, Cdkn1b, and Cdkn1c
by GATA factors during cardiac development. The levels of p21cip1
are also known to increase in cardiomyocytes shortly after birth
and are thought to be partially responsible for the withdrawal
from the cell cycle of postnatal cardiomyocytes (Evans-Anderson
et al., 2008; Poolman et al., 1998). The level of FOG-2 expression
also changes postnatally; it is expressed at lower levels in the adult
heart than in the embryonic heart (Kim et al., 2009). Thus, the
postnatal increase in p21cip1 may be mediated by decreasing FOG-
2 levels and lack of repression of Cdkn1a by FOG-2/NuRD.
Previously, transcriptional regulation of Cdkn1a has been
shown to play a critical role in skeletal muscle development.
During skeletal muscle regeneration, the transcription factor
FoxK1 is important for proliferative ability and functions by
repressing the expression of Cdkn1a (Hawke et al., 2003a,
2003b). In FoxK1 deﬁcient mice, skeletal muscle proliferation is
impaired due to the overexpression of Cdkn1a. The amount that
Cdkn1a is overexpressed in FoxK1-deﬁcient skeletal muscle regen-
eration is similar to the level of overexpression of Cdkn1a that we
observe in developing cardiomyocytes in FOG2R3K5A hearts. Also,
in FoxK1 deﬁcient mice, skeletal muscle proliferation can be
rescued by genetically ablating Cdkn1a. Unlike the complete
proliferative rescue observed in these mice, the rescue that we
observe in ventricular wall thickness when crossing FOG-2R3K5A
mice to Cdkn1a deﬁcient mice is only partial. The lack of complete
rescue suggests a more complex mechanism for cardiomyocyte
cell cycle control by FOG-2/NuRD that is only partially dependent
on the transcriptional repression of Cdkn1a.
In summary, we have deﬁned a novel pathway involving the
NuRD chromatin remodeling complex in cardiomyocyte cell cycle
control through its interaction with FOG-2. This is likely just one of
many roles that the NuRD complex is playing during cardiac
development, but the further elucidation of these roles must await
the generation and characterization of mice with cardiomyocyte
speciﬁc deletions of the NuRD complex.
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